Abstract-In this paper, we develop a method of detecting 1,3,5-trinitroperhydro-1,3,5-triazine [research department explosive (RDX)]. RDX is one of the main components of plastic explosives. Initially, we prepare an anti-RDX monoclonal antibody that specifically binds to RDX. The antibody is prepared from hybridoma cells that are prepared by the iliac lymph node method. The dissociation constant of the antibody against RDX is estimated to be 9.6 nM from the results of indirect competitive enzyme-linked immunosorbent assay. We fabricate a sensor chip on which RDX analogues are immobilized through a self-assembled monolayer with oligo(ethylene glycol) chains. High reliability and low false recognition rate are particularly required for sensors used for detecting explosives. Therefore, the nonspecific adsorption of the fabricated sensor chip is evaluated to confirm whether the sensor chip inhibits this nonspecific adsorption. The response characteristics of the prepared antibody against RDX are examined by indirect competitive assay. Under an incubation time of 0 min in the indirect competitive assay, a detection limit of 40 ppt is realized at a sample injection duration of 6 min.
rapid measurement, and low false recognition rate are the technical characteristics required of these devices [1] . Ease of maintenance, ease of operation, and high portability are also necessary.
Various explosive detection methods currently used have some disadvantages. We have proposed a method that uses a surface plasmon resonance (SPR) immunosensor to satisfy the above requirements [2] . Thus far, we have examined the detection of 2,4,6-trinitrotoluene and 2,4-dinitrotoluene [3] . Furthermore, the structure and other factors of the sensor surfaces have been improved [4] [5] [6] [7] .
Minute changes in permittivity around the sensor surface can be detected in real time using SPR immunosensors. A high selectivity is realized by combining antigen-antibody interactions with SPR sensor to bind to a target specifically. However, SPR immunosensors can only detect changes in permittivity. Namely, SPR immunosensors cannot distinguish a change in permittivity caused by antigen-antibody interactions from that caused by other factors. Therefore, a structure that can inhibit nonspecific adsorption, i.e., adsorption not caused by antigenantibody interactions, should be preliminarily formed on the sensor surface to realize a high-precision sensor with a low false recognition rate. Preliminary labeling of the target is not necessary for SPR immunosensors; thus, they are suitable for real-time rapid tests at detection sites. In addition, SPR immunosensors are economically advantageous because they require only a small amount of samples for measurement and sensor chips can be reused after a regeneration process for only a few minutes. Moreover, they are small and can be installed in portable measurement devices.
The purpose of this study is to establish a highly sensitive method of detecting 1,3,5-trinitroperhydro-1,3,5-triazine [research department explosive (RDX); C 3 H 6 N 6 O 6 ; molecular weight, 222.12] using an SPR immunosensor. Compared with trinitrotoluene (TNT), the most commonly used explosive, RDX has a high explosive power. RDX is the main component of a plastic explosive composition C-4, which is frequently used in the military.
Studies on the detection of RDX have been reported in several papers. They include (1) the detection of explosives attached on a surface using lasers [8] , (2) the detection of explosives using optical fibers [9] , [10] , (3) incorporating π-π interaction into an SPR immunosensor [11] , and (4) the detec- tion of explosives based on antigen-antibody interactions of antigen analogues or antibodies that are fluorescently labeled or labeled with a dye [12] [13] [14] . Some papers reported the extraction and detection of RDX from real samples, such as groundwater and plasma [15] . However, practical applications of the methods previously reported seem difficult to realize, considering the various sites where the explosive sensors will be actually used, in terms of sensitivity, selectivity, measurement time, and cost.
A stable supply of antibodies is indispensable for the practical application of SPR immunosensors. In addition, it is preferable that the properties of the supplied antibodies be uniform. Considering these requirements toward practical application in mind, monoclonal antibodies are optimal for this purpose. Monoclonal antibodies are continuously available and exhibit uniform properties.
In this study, we prepared an original monoclonal antibody against RDX. We also fabricated a sensor chip on which RDX analogues are immobilized via a self-assembled monolayer (SAM) with oligo(ethylene glycol) chains. Nonspecific adsorption was evaluated and the amount of RDX was measured by indirect competitive assay using the SPR immunosensor we developed.
II. PREPARATION OF ANTIBODY

A. Reagents and Instruments
RDX
solution and two RDX haptens, i.e., (1,3,5-trinitrohexahydropyrimidin-5-yl) methylhemiglutarate (RDXa1; C 10 H 15 N 5 O 10 ; molecular weight, 365.25) and 5-(2-carboxyethyl)-1,3,5-trinitrohexahydro pyrimidine (RDXa2; C 7 H 11 N 5 O 8 ; molecular weight, 293.21), were purchased from Chugoku Kayaku Co., Ltd. Fig. 1 shows structural formula of RDX, RDXa1 and RDXa2 [16] . Keyhole-limpet hemocyanin (KLH), used as the carrier protein, was purchased from Pierce Biotechnology, Inc. We prepared hapten protein complex antigens using these reagents.
ELISA measurements were performed using 96-well immunoplates (NUNC, No. 446612, Roskilde, Denmark) and a microplate reader (Wallac 1420, Perkin Elmer Life Science Japan, Tokyo, Japan). o-phenylene diamine (o-PD) and gelatin were obtained from Nacalai Tesque, Inc. (Kyoto, Japan). Horse radish peroxidase labeled polyclonal rabbit anti-rat immunoglobulin G (HRP-anti-rat IgG) was from Daco Japan Co. (Tokyo, Japan). Ovalbmin (OVA) was obtained from Sigma (St. Louis, Mo, USA).
1) RDXa1-KLH: 13 mg of N-hydroxysuccinimide (NHS) and 50 mg of sodium sulfate was added to RDXa1 (1 ml) prepared at a concentration of 4.5 mg/ml using bis(2-methoxyethyl) ether, and stirred. 25 mg of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) was then added to the solution obtained and then stirred overnight at room temperature. The resulting activated RDXa1 solution (20 μl) was slowly added to a solution in which 21 mg of KLH was dissolved in 3 ml of 25 mM borate buffer (pH 8.0), three times at 30 min intervals. After the solution was allowed to react for 3 h, the reaction solution was dialyzed against deionized water overnight and freeze-dried to obtain RDXa1-KLH.
2) RDXa1-OVA: 2.3 mg of NHS and 50 mg of sodium sulfate was added to RDXa1 (1 ml) prepared at a concentration of 4.5 mg/ml using N,N-dimethylformamide (DMF), and stirred. 38 mg of EDC was then added to the solution obtained and then stirred overnight at room temperature. The resulting activated RDXa1 solution (20 μl) was slowly added to a solution in which 7 mg of OVA was dissolved in 1 ml of 12.5 mM borate buffer (pH 8.0), three times at 30 min intervals. After the solution was allowed to react for 3 h, the reaction solution was dialyzed against deionized water overnight and freeze-dried to obtain RDXa1-OVA.
B. Preparation Procedure
Rat anti-RDX monoclonal antibodies were prepared by the iliac lymph node method using RDXa1-KLH as the immunogen [17] . Four Wistar-Kyoto rats (WKYs) (8 weeks old, female) were immunized with RDXa1-KLH and euthanized after an immunization period of 14-21 days, and their whole blood was collected. After laparotomy, a pair of iliac lymph nodes was isolated. All animal experiments were conducted under the control of the guideline for Animal Experiment in Kyushu University and the Law (No. 105) and Notification (No. 6) of the Government. The lymph cells extracted from the isolated lymph nodes were stored by freezing. The lymph cells collected from the four rats were used for one-cell fusion at a later date.
The lymph and myeloma cells were fused by the polyethylene glycol (PEG) method. The fused cells were then suspended in hypoxanthine-amethopterin-thymidine (HAT) medium, seeded in a 96-well plate, and incubated in HAT medium for one week for selection.
After one week of incubation in HAT medium, the culture supernatant was sampled from the wells and used to screen for the anti-RDX antibody strain by indirect competitive enzymelinked immunosorbent assay (ELISA). ELISA plates were coated with 100 μL of RDXa1-OVA (5 μg/ml phosphate buffered saline; PBS) and were blocked with 1% gelatin. 40 μL of the supernatant (antibodies) of each cultured well were added to each well. RDX was added at the final concentration of 0.5 μg/mL and then RDX was reacted with antibodies at room temperature for 90 min. The plates were washed with PBS containing 0.05% Tween 20 (PBST), and then reacted with 100 μL of HRP-anti-rat IgG (1 μg/mL) for 60 min at room temperature. After washing with PBST, 100 μL of the substrate solution (0.4 μl/mL 30% hydrogen peroxide solution, 0.4 mg/mL o-PD in PBS) was added to each well and incubated for 20 min. 3 M sulfuric acid was added to each well and the enzyme reaction was stopped The absorbance at 490 nm was measured. The subsequent procedures for experiments were almost the same as above. By the results of the screening, four colonies which has the high absorbance when no RDX was added and the low inhibitory rate B/B 0 % were obtained. They were increased to 1 ml using a 24-well plate. In addition, the medium was changed from HAT medium to hypoxanthine-thymidine (HT) medium (10% BM Condimed H1, 90% SGIT medium). After confirming the proliferation on a 1-ml scale, cloning was carried out by limiting dilution. After the confirmation of cloning, the strains were acclimated sequentially in HT medium, 5% BM Condimed H1-containing SGIT medium, and then SGIT medium, and the obtained strains were stored in several vials. We selected a strain that can produce antibodies with the highest ability to bind to RDX by carrying out indirect competitive ELISA using the culture supernatant obtained using the 10-ml scale.
We mass-cultured strains that can produce antibodies with the highest binding ability against RDX in order to obtain a large amount of monoclonal antibodies. First, hybridoma cells were acclimated from SGIT medium to 5% BM Condimed H1-containing SGIT medium to improve their proliferative potential and antibody production ability. Then, they were acclimated to 5% BM Condimed H1-containing BD serumfree medium and then cultured in a flask with BD CELLine for one week. Finally, monoclonal antibodies were obtained by purifying the hybridoma supernatant collected from a cellculture chamber using a protein G column.
C. Specificity of Rat Anti-RDX Monoclonal Antibody Against RDX
The cross reactivities of the anti-RDX monoclonal antibody against RDX and related compounds were examined by indirect competitive ELISA (TABLE I) . IC 50 is the half maximal (50%) inhibitory concentration and cross reactivity [C.R. (%)] is the ratio of the IC 50 of an RDX analogue to the IC 50 of RDX, assuming that the IC 50 of RDX is 100. The antibody showed strong binding to RDX and two types of RDX hapten, i.e., RDXa1 and RDXa2, but weak binding to TNT. The binding ability of the antibody for RDXa1, a hapten used to prepare the antibody, is at least ten times higher than that to RDX. This finding indicates that the antibody interacts with a structure of RDXa1 other than the RDX skeleton, i.e., the linker region. Similarly, the ability of binding of the antibody to RDXa2 is approximately four times higher than that to RDX. It would appear that lack of a third nitrogen plays a role in the recognition also. Significant binding to RDX implies that the ring structure is also being recognized by the antibody. From the above discussion, the monoclonal antibody is considered to have a high specificity to RDX.
The dissociation constant K d of the anti-RDX monoclonal antibody was determined by indirect competitive ELISA using Seligman's method. The absorbance was measured three times at each concentration. Standard deviations were below 5% at each concentration. a 0 is the initial number of antigens, i 0 is the initial number of antibodies (number of binding sites), and x is the number of antigen-antibody bindings. When the percentage of the number of antigen-antibody bindings to the number of binding sites is denoted Figure 2 shows the dissociation constant of the rat anti-RDX monoclonal antibody determined by indirect competitive ELISA. K d as high as 9.6 nM was obtained, indicating that the antibody is suitable for high-sensitivity measurement.
III. EXPERIMENTAL PROCEDURE
A. Measurement System
In this study, BIACORE X (GE Healthcare) was used as the SPR immunosensor. With BIACORE X, the change in permittivity was obtained from the change in the resonance angle of SPR; here, 0.1 • of the change in resonance angle is output as 1000 resonance unit (RU). The change of 1000 RU corresponds to a change of 1 ng/mm 2 of the protein on the sensor surface. A sensor chip provided in the SIA kit (GE Healthcare) was attached to the sensor. 250 μl of 10% surfactant Tween 20 was added to 49.75 ml of 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered saline (HBS) (HEPES buffer + 150 mM NaCl; pH, 7.4), and the solution obtained was used as the running buffer. 50 mM NaOH was used as the regeneration solution. The running buffer was filtered before use and completely deaerated. The flow rate of the running buffer was set at 10 μl/min during the measurement.
B. Reagents
A solution of RDX (9.7 ppm; Chugoku Kayaku Co., Ltd.), the target of the measurement in this study, was diluted with the prepared buffer. The rat anti-RDX monoclonal antibody prepared as described in chapter II was used as the antibody. RDXa2 was used as the antigen analogue that is considered to bind to the antibody by cross reaction.
PEG6-COOH aromatic dialkanethiol was purchased from Senso Path Technologies (Bozeman, MT, USA). Fig. 3 shows a fabrication process of the sensor chip. The antigen analogue was immobilized on the surface of the sensor chip. Before the immobilization, the sensor chip was preliminarily cleaned with acetone for 10 min, with ethanol for 2 min, and with 2-propanol for 2 min in an ultrasonic bath, and then heated to 90 • C in a standard clean (SC) 1 solution (ammonia water: hydrogen peroxide water: Milli-Q water = 1:1:5) for cleaning for 20 min.
C. Fabrication of the Sensor Chip
The precleaned sensor chip was immersed in 1 mM PEG6-COOH aromatic dialkanethiol ethanol solution for 24 h to form a SAM on the sensor chip. The sensor chip obtained was ultrasonically cleaned in ethanol. A solution of a mixture of 0.4 M EDC and 0.1 M NHS was dropped on the sensor chip and allowed to stand for 30 min. This activated carboxyl groups at the SAM terminals. At the same time, a mixture of 0.4 M EDC, 0.1 M NHS in DMF, and 10 mM RDXa2 in DMF (EDC:NHS DMF:RDXa2 DMF = 1:1:1) was prepared, to which an appropriate amount of triethylamine DMF solution was added to control the pH to approximately 8.5; it was then allowed to stand for 60 min. This activated the carboxyl groups of RDXa2. After dropping 100 mM ethylendiamine in borate buffer (pH 8.5) on the sensor chip, the sensor chip was allowed to stand for 30 min for the activated carboxyl groups to react with one terminal amino group of ethylenediamine; ethylenediamine was then immobilized on the SAM. The mixture of solutions that was allowed to stand for 60 min, as described above, was dropped on the sensor chip, and then allowed to stand for another 60 min for the carboxyl groups of RDXa2 to bind to terminal amino groups that had not reacted with the activated carboxyl groups at the SAM terminals. RDXa2 was immobilized by this procedure.
D. Evaluation of Nonspecific Adsorption
Nonspecific adsorption of the sensor chip was evaluated using bovine serum albumin (BSA) and lysozyme. BSA was negatively charged, whereas lysozyme was positively charged in the HBS used for measurement. Nonspecific absorption is caused by electrostatic or hydrophobic interaction; it is evaluated using BSA and lysozyme [18] .
The concentrations of BSA and lysozyme were both 1000 ppm and the injection volumes of these solutions were both 30 μl during measurement. The sensor chip fabricated as described in section III.C [sensor chip (B)] was used for measurement. A control experiment was carried out using the sensor chip CM5 (GE Healthcare), to which carboxymethyl-dextran, instead of PEG6-COOH aromatic dialkanethiol, was modified, and on which RDXa2 was immobilized via ethylenediamine [sensor chip (A)]. CM5 is a versatile sensor chip used in experiments using Biacore Systems.
E. Measurement
Measurement was carried out using sensor chip (B) by indirect competitive assay. First, an antibody solution with a predetermined concentration was injected to bind the antibodies to the antigen analogues on the sensor chip surface. The change in the sensor response ( θ 0 ) depends on the amount of injected antibodies that bound to antigen analogues on the sensor chip surface (hereafter, amount of binding). A solution obtained by mixing and binding antibodies of predetermined concentration and antigens of several known concentrations was injected to obtain a change in the sensor response ( θ 1 ). Here, the antibodies that had already bound to antigens in the solution did not bind to antigens on the sensor chip surface, resulting in a decreased amount of binding. The higher the concentration of antigens in the mixed solution, the lower the extent of binding. Thus, the concentration of the antigens in the solution can be estimated indirectly from the extent of binding. Binding percentage, i.e., the ratio of θ 1 to θ 0 , was used as a parameter for evaluation. A calibration curve of RDX can be obtained by measuring binding percentage for the mixture of the antigen of several known concentrations and the predetermined concentration of the antibody.
Eighty nanograms per milliliter (ppb) of RDX antibody stock solutions were mixed with varying concentration of RDX solution (0, 2, 20, and 200 pg/ml (ppt); 2, and 20 ng/ml) in 1:1 volume ratio (final concentration of RDX antibody in each sample solution was 40 ng/ml, and that of RDX was 0, 1, 10, and 100 pg/ml; 1, and 10 ng/ml, respectively). When 200 ng/ml of RDX antibody was used, RDX solution 0, 20, and 200 pg/ml; 2, 10, and 20 ng/ml were used.
Incubation time was generally set in the indirect competitive assay so that the antibody and antigen solutions can react beforehand. However, in the case of detecting explosives in actual field test, rapid measurement is desirable. Therefore, incubation time was set at 0 or 15 min in the experiment, and the results were compared.
IV. RESULTS AND DISCUSSION
BSA and lysozyme were injected into sensor chips (A) and (B). TABLE II shows a summary of the responses obtained. Nonspecific adsorption was scarcely observed on sensor chip (A), but that of lysozyme observed on sensor chip (B). To explain this, two reasons are considered. The oligo(ethylene glycol) chain in PEG6-COOH aromatic dialkanethiol helps maintain the hydrophilic nature of the sensor chip surface. Moreover, antigen analogues are highly oriented in the presence of a SAM. Therefore, the number of unreacted functional groups, such as carboxyl and amino groups, is small, which results in a state close to the charge neutrality of the sensor chip surface. Therefore, RDX measurement with high reliability and low false recognition rate can be realized using sensor chip (B). Next, the amount of RDX was measured by indirect competitive assay using sensor chip (B). Measurement was carried out three times each under conditions in which a response of 100-160 RU was obtained upon injection of an antibody solution. A representative sensorgram is shown in Fig. 4(a) . The measurement conditions are as follows: antibody concentration, 40 ppb; injection volume, 60 μl; incubation time, 0 min. As shown in Fig. 4(a) , there is a difference between the responses observed when the antibody is mixed with 0 ppt RDX (standard) and 1 -10,000 ppt RDX. After injecting a mixture of antibody and RDX solution, the sensor response increased around 120 RU rapidly; this phenomenon, bulk effects, was due to the minimal difference in refractive index between the running buffer and the solvent of RDX solution. The amplitude of response decreases as RDX concentration increases. Figure 4 (b) shows overlaid sensorgrams shown in Fig. 4(a) . These response curves were adjusted at 0 with subtracting responses increased by bulk effects. Figure 5 shows the calibration curve obtained from the results of all cycles.
TABLE III shows a summary of the final concentrations of the antibody, injection volumes, incubation times, and detection limits under different conditions. Under all the conditions, the extent of binding depends on the RDX concentration of the solution of the antibody and RDX. Detection limit was calculated such that the decrease in binding percentage is threefold the standard deviation. Relative antigen concentration increased with decreasing antibody concentration. Therefore, detection limit improved at low antibody concentrations. The detection limit was 40 ppt at an antibody concentration of 40 ppb at 0 min of incubation. There is a slight difference of detection limit between the condition (ii) and (iii). However, the characteristics of these curves almost same. It is probable that this difference is not caused by incubation time. RDX can be detected with high sensitivity on both conditions.
V. CONCLUSION
The purpose of this study was to establish a highly sensitive detection method for RDX using an SPR immunosensor that enables highly sensitive and easy measurement.
The rat anti-RDX monoclonal antibody was prepared from hybridoma cells prepared by the iliac lymph node method using RDXa1-KLH as the immunogen. We confirmed that the antibody has a high specificity against RDX by the cross-reactivity test. The dissociation constant of the antibody against RDX was estimated to be 9.6 nM from the results of indirect competitive ELISA. Nonspecific adsorption was evaluated by injecting BSA and lysozyme into the fabricated sensor chips on which RDX analogues are immobilized. Indirect competitive assay was carried out using the sensor chip with RDX analogues immobilized on a SAM with oligo(ethylene glycol) chains, which highly inhibit nonspecific adsorption. A detection limit of 40 ppt was realized at an antibody concentration of 40 ppb, an injection volume of 60 μl, and an incubation time of 0 min. Highly sensitive and rapid measurement of RDX was possible by optimizing the conditions, i.e., using an antibody that has a high binding ability for RDX and a sensor chip that inhibits nonspecific adsorption.
